David Benito Laorga’s Haemophilia Team Hosts Hemosfera
David Benito Laorga, Business Unit Director and Management Team Member Novo Nordisk Spanish Affiliate, shared on LinkedIn:
”This weekend, our haemophilia team hosted Hemosfera, a truly innovative meeting centered on a new treatment with the potential to reduce treatment burden, improve quality of life, and open new possibilities for patients and families.
I’m especially proud of the team behind the scenes.
From concept to execution, this event was powered by strong ownership, deep commitment, and a shared conviction that meaningful innovation requires doing things differently—and doing them well.
This is what high-performing teams look like.
My sincere thanks as well to all the speakers for the depth and quality of the discussions.
Your insights and engagement were critical to making this a truly valuable and impactful event.
Proud of the team. Motivated by the impact we can create for patients.”
Stay updated with Hemostasis Today.
-
May 10, 2026, 18:07Recurrent DVT and PE in Young Adults May Indicate an Underlying Cause – The Lancet Group
-
May 10, 2026, 18:06Noemi Zampatti: Pediatric Celiac Crisis Complicated by Refeeding Syndrome and Proposed Diagnostic Criteria
-
May 10, 2026, 18:05Giovanni Solimeno: When the Common Femoral Artery Wall is Diseased, Closure is Not a Step
-
May 10, 2026, 18:04Maitri Vaishnav: The Bombay Blood Group and the Critical Role of the H Antigen
-
May 10, 2026, 18:03Nicolas Hubacz: Mesenchymal Stem Cells Are Some of the Most Fascinating Cells in Regenerative Medicine
-
May 10, 2026, 16:20Joshua Ngimbwa: How Sex and Socioeconomic Factors Influence Stroke Outcomes in Tanzania
-
May 10, 2026, 16:18Gustavo Monnerat: How Thousands of Fake References Slipped Into Biomedical Literature
-
May 10, 2026, 16:13Dalius Jatužis: Our AI-Driven Automated Stroke Registry Data Extraction Gets Best Poster Award at ESOC 2026
-
May 10, 2026, 16:11Full House for Breakfast with the Experts – American Society for Apheresis